Vickie L Capps
CIK 1248190 · Executive VP, CFO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SBTX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
VISTA, CA 92083
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JANX | Director | 79,598 | $16.69 | $1.33M | $0 | 7 | 2026-06-12 |
| OFIX | Director | 43,300 | $9.78 | $423.5K | $62.3K | 4 | 2026-06-12 |
| AMEDISYS INC (AMED) Delisted | Director | 0 | $100.99 | $0 | $187.0K | 9 | 2025-08-14 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $96.5K | 11 | 2023-09-05 |
| OTONOMY, INC. (OTIC) Delisted | Director | 5,000 | $0.08 | $385 | $117.4K | 11 | 2022-11-29 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | 61,576 | $5.87 | $361.5K | $200.0K | 4 | 2022-06-13 |
| THOR | Director | — | $25.39 | — | $0 | 2 | 2020-01-24 |
| CONNECTURE INC (CNXR) Delisted | Director | 136,898 | — | — | $24.1K | 5 | 2017-05-25 |
| SENORX INC (SENO) Delisted | Director | 15,652 | — | — | $72.8K | 5 | 2010-07-07 |
| DJO INC (PXR) Delisted | Executive VP, CFO | 32,837 | — | — | $34.6K | 4 | 2007-05-30 |
Recent Filings · Page 5 of 7
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-27 | — | Disp (D) | −136,898 | -$47.9K | |
| 2017-07-14 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-25 | CONNECTURE INC (CNXR) Delisted | Grant (A) | +80,488 | $0 | EDGAR |
| 2017-05-22 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-02 | CONNECTURE INC (CNXR) Delisted | Grant (A) | +27,160 | $0 | EDGAR |
| 2016-06-21 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-14 | CONNECTURE INC (CNXR) Delisted | Buy (P) | +15,000 | $24.1K | EDGAR |
| 2016-05-23 | NUVASIVE INC (NUVA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-23 | CONNECTURE INC (CNXR) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2015-06-22 | OTONOMY, INC. (OTIC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.